GENFLOW BIOSCIENCES PLC
GENF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BP2C3V08
- LEI:
- 213800HVOFXRXVEGDN62
- Country:
- United Kingdom
- Address:
- 6 HEDDON STREET, W1B 4BT LONDON
- Website:
- https://genflowbio.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Genflow Biosciences PLC is a UK-based biotech firm dedicated to discovering and advancing new therapeutic approaches to halt or slow the ageing process for longer, healthier lives.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-12 11:16 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 30.5 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
Genflow Signs Master Services Agreement
|
English | 13.4 KB | |
| 2025-05-15 08:00 |
Regulatory News Service
Key SIRT6 Patent Application
|
English | 12.3 KB | |
| 2025-05-12 11:50 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 68.7 KB | |
| 2025-05-07 19:07 |
Annual Report (ESEF)
Annual financial statements 2024
|
English | 493.4 KB | |
| 2025-05-07 19:07 |
Annual Report
Annual financial statements 2024
|
English | 1.5 MB | |
| 2025-02-20 08:00 |
Regulatory News Service
Advancements in SIRT6 Variant Patent Application
|
English | 19.4 KB | |
| 2025-01-13 08:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.3 KB | |
| 2025-01-13 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 24.4 KB | |
| 2025-01-06 08:00 |
Regulatory News Service
2024 Highlights
|
English | 18.9 KB | |
| 2024-10-22 08:00 |
Regulatory News Service
Genflow Secures Non-Dilutive Financial Support
|
English | 18.0 KB | |
| 2024-09-30 08:00 |
Earnings Release
Half-year Report
|
English | 204.4 KB | |
| 2024-06-28 12:40 |
Declaration of Voting Results & Voting Rights Announcements
Print of Ordinary and Special Resolutions
|
English | 51.6 KB | |
| 2024-06-27 14:30 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 11.2 KB | |
| 2024-06-27 08:00 |
Regulatory News Service
Strengthening of Pre-Clinical Efforts
|
English | 18.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nykode Therapeutics ASA | Norway | NYKD | |
|
Oculis Holding AG | Switzerland | OCS | |
|
ONCODESIGN | France | ALONC | |
|
Oncodesign Precision Medicine S.A | France | ALOPM | |
|
Oncoinvent ASA | Norway | OCIN | |
|
Oncopeptides | Sweden | ONCO | |
|
Onxeo | France | ALONX | |
|
OPKO Health Inc. | Israel | OPK | |
|
Oramed Pharmaceuticals Inc. | Israel | ORMP | |
|
Oryzon Genomics S.A. | Spain | ORY |